| Kip McGrath Education Centres Limited (KME) ORDINARY FULLY PAID |
Consumer Discretionary |
$38 |
KME Announcement of buy-back - Appendix 3C
|
26 Aug 2025 9:24AM |
$0.605 |
$0.720 |
risen by
19.01%
|
|
KME - Price-sensitive ASX Announcement
Full Release
Key Points
- Kip McGrath Education Centres Limited (KME) announced an on-market buy-back of ordinary shares.
- The announcement is made in compliance with ASX Listing Rule 3.8A and is detailed in Appendix 3C.
- The buy-back will occur on the ASX and involves up to 4,073,928 ordinary shares, representing 5% of the company's issued capital.
- The buy-back period is from 24 June 2024 to 23 June 2025.
- The reasons for the buy-back include capital management and enhancing shareholder value.
- All shares purchased under the buy-back will be cancelled.
- KME has provided the necessary authorizations and confirmations regarding the legitimacy and compliance of the buy-back.
- No selective buy-backs or off-market buy-backs are involved; it is solely an on-market process.
- The buy-back is not expected to have a material adverse effect on the company's financial position.
- Directors and related parties may participate in the buy-back if they sell shares on-market.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kip McGrath Education Centres Limited (KME) ORDINARY FULLY PAID |
Consumer Discretionary |
$38 |
Dividend/Distribution - KME
|
26 Aug 2025 9:24AM |
$0.605 |
$0.720 |
risen by
19.01%
|
|
| Horizon Gold Limited (HRN) ORDINARY FULLY PAID |
Materials |
$190 |
Application for quotation of securities - HRN
|
26 Aug 2025 9:23AM |
$0.500 |
$0.975 |
risen by
95%
|
|
| Nufarm Limited (NUF) ORDINARY FULLY PAID |
Materials |
$1,114 |
Trading Update
|
26 Aug 2025 9:23AM |
$2.580 |
$2.900 |
risen by
12.40%
|
|
| Structural Monitoring Systems Plc (SMN) CHESS DEPOSITARY INTERESTS 1:1 |
Information Technology |
$58 |
Strategic Leadership Appointment - Interim AEM CEO
|
26 Aug 2025 9:23AM |
$0.545 |
$0.370 |
fallen by
32.11%
|
|
| Clime Investment Management Ltd (CIW) ORDINARY FULLY PAID |
Financials |
$25 |
Update - Notification of buy-back - CIW
|
26 Aug 2025 9:23AM |
$0.390 |
$0.300 |
fallen by
23.08%
|
|
| Corporate Travel Management Limited (CTD) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,351 |
Update on consolidated FY25 Full Year Results
|
26 Aug 2025 9:23AM |
$16.070 |
$16.070 |
fallen by
0%
|
|
CTD - Price-sensitive ASX Announcement
Full Release
Key Points
- CTM revises FY25 full year underlying EBITDA guidance to AUD 240-260 million.
- The revision is due to changes in travel demand and market dynamics.
- Regional performance and client activity influenced the updated expectations.
- CTM remains focused on client service, technology, and efficiency.
- The company continues to pursue its growth strategy and competitive positioning.
- Outlook commentary includes ongoing market challenges and opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Abacus Group (ABG) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$791 |
Notice of withdrawal of NON-BINDING INDICATIVE PROPOSAL
|
26 Aug 2025 9:23AM |
$1.295 |
$0.885 |
fallen by
31.66%
|
|
| Integral Diagnostics Limited (IDX) ORDINARY FULLY PAID |
Health Care |
$836 |
Appendix 4E and FY25 Annual Report
|
26 Aug 2025 9:23AM |
$2.720 |
$2.240 |
fallen by
17.65%
|
|
IDX - Price-sensitive ASX Announcement
Full Release
Key Points
- Integral Diagnostics Limited (IDX) released its Appendix 4E and FY25 Annual Report.
- The report provides a comprehensive review of the financial year ending 30 June 2025.
- IDX reported strong revenue growth, driven by increased demand for diagnostic imaging services across its network.
- The company continues to focus on strategic acquisitions and organic growth to expand its footprint in Australia and New Zealand.
- IDX highlighted operational efficiencies achieved through investments in technology and streamlined processes.
- There was a significant improvement in EBITDA and net profit after tax compared to the previous fiscal year.
- The Board declared a final dividend for shareholders, reflecting confidence in future cash flows.
- The report discusses ongoing challenges in workforce supply, inflationary pressures, and regulatory changes affecting the healthcare sector.
- IDX remains committed to delivering high-quality patient outcomes and maintaining strong relationships with referrers and partners.
- The company outlined its sustainability initiatives and commitment to environmental, social, and governance (ESG) principles.
- Future outlook is positive, with expectations of continued growth supported by demographic trends and technological advancements in medical imaging.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Integrated Research Limited (IRI) ORDINARY FULLY PAID |
Information Technology |
$53 |
Appendix 4G and Corporate Governance Statement
|
26 Aug 2025 9:22AM |
$0.455 |
$0.295 |
fallen by
35.16%
|
|
| True North Copper Limited (TNC) ORDINARY FULLY PAID |
Materials |
$67 |
New drill targets confirmed at Aquila - drilling underway
|
26 Aug 2025 9:22AM |
$0.330 |
$0.430 |
risen by
30.30%
|
|
TNC - Price-sensitive ASX Announcement
Full Release
Key Points
- True North Copper Limited (TNC) reported new drill targets at Aquila within the Mt Oxide Project, Queensland.
- RC drilling has commenced on high-priority copper sulfide targets adjacent to the existing Aquila Mineral Resource.
- The new targets were identified via multidisciplinary data integration including geological, geochemical, and geophysical datasets.
- These targets are shallow and considered prospective for expanding the current Mineral Resource.
- The drilling campaign is designed to test the potential for increased resource size and confidence.
- The announcement reinforces the prospectivity of the Mt Oxide Project and TNC’s strategy to advance its copper portfolio in Queensland.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rhythm Biosciences Limited (RHY) ORDINARY FULLY PAID |
Health Care |
$29 |
ColoSTAT Kit Validation Completion and NATA Submission
|
26 Aug 2025 9:22AM |
$0.105 |
$0.081 |
fallen by
22.86%
|
|
RHY - Price-sensitive ASX Announcement
Full Release
Key Points
- RHY completed validation of the ColoSTAT Kit for colorectal cancer detection.
- ColoSTAT Kit application submitted to NATA for accreditation in Australia.
- Validation demonstrated strong sensitivity and specificity consistent with prior studies.
- Accreditation is a necessary step for commercial launch in Australia.
- RHY plans to expand regulatory submissions to international markets.
- The company is exploring commercial partnerships and distribution opportunities.
- ColoSTAT Kit is positioned as a significant advancement in early colorectal cancer detection.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tribeca Global Natural Resources Limited (TGF) ORDINARY FULLY PAID |
Financials |
$192 |
Investor Presentation
|
26 Aug 2025 9:22AM |
$1.455 |
$2.610 |
risen by
79.38%
|
|
| Integrated Research Limited (IRI) ORDINARY FULLY PAID |
Information Technology |
$53 |
FY25 Results Presentation
|
26 Aug 2025 9:22AM |
$0.455 |
$0.295 |
fallen by
35.16%
|
|
| Integrated Research Limited (IRI) ORDINARY FULLY PAID |
Information Technology |
$53 |
FY25 Full Year Results
|
26 Aug 2025 9:22AM |
$0.455 |
$0.295 |
fallen by
35.16%
|
|
IRI - Price-sensitive ASX Announcement
Full Release
Key Points
- FY25 revenue and net profit declined year-on-year, primarily due to lower license sales and the shift to subscription models.
- Cost control and operational efficiency initiatives remained central to the company’s strategy during the financial year.
- Strong cash position and zero debt were maintained, supporting ongoing investments in innovation and operations.
- No final dividend was declared for the year as the company focuses on reinvestment and strengthening its market position.
- Continued investment in cloud and hybrid product offerings to address changing customer requirements.
- Emphasis on enhancing go-to-market execution and customer engagement to drive future growth.
- Outlook remains cautious but optimistic, with a focus on delivering sustainable value to shareholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Integrated Research Limited (IRI) ORDINARY FULLY PAID |
Information Technology |
$53 |
Dividend/Distribution - IRI
|
26 Aug 2025 9:21AM |
$0.455 |
$0.295 |
fallen by
35.16%
|
|
| Cyprium Metals Limited (CYM) ORDINARY FULLY PAID |
Materials |
$283 |
Trading Halt
|
26 Aug 2025 9:21AM |
$0.030 |
$0.490 |
risen by
1,533.33%
|
|
CYM - Price-sensitive ASX Announcement
Full Release
Key Points
- Cyprium Metals Limited requested a trading halt on 11 June 2024.
- The trading halt is due to a pending announcement relating to a proposed capital raising.
- The halt will last until 13 June 2024 or until the announcement is made.
- The ASX approved the trading halt to maintain an orderly market.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Carindale Property Trust (CDP) ORDINARY UNITS FULLY PAID |
Real Estate |
$453 |
Appendix 4G
|
26 Aug 2025 9:21AM |
$5.380 |
$5.480 |
risen by
1.86%
|
|
| Integrated Research Limited (IRI) ORDINARY FULLY PAID |
Information Technology |
$53 |
Appendix 4E and FY25 Financial Report
|
26 Aug 2025 9:21AM |
$0.455 |
$0.295 |
fallen by
35.16%
|
|
IRI - Price-sensitive ASX Announcement
Full Release
Key Points
- Statutory revenue and profit for the year ended 30 June 2023 declined compared to the prior year.
- The company is transitioning from perpetual license sales to a subscription/SaaS model to align with market trends.
- Investment in new cloud-based offerings and restructuring activities to improve operational efficiency.
- Leadership changes occurred, including a new CEO and Board appointments.
- No final dividend was declared for FY23 due to lower profits and a focus on reinvestment.
- Risks highlighted include transformation execution, changing market conditions, and reliance on key customers.
- Comprehensive corporate governance, remuneration, risk management, and audit practices are described.
- The annual report includes statutory financial statements, directors’ report, auditor’s report, and detailed notes.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Imugene Limited (IMU) ORDINARY FULLY PAID |
Health Care |
$40 |
Appendix 4E and Annual Report
|
26 Aug 2025 9:20AM |
$0.265 |
$0.082 |
fallen by
69.06%
|
|
IMU - Price-sensitive ASX Announcement
Full Release
Key Points
- Imugene Limited is a biotechnology company focused on immunotherapies for cancer.
- The Appendix 4E and Annual Report is for the year ended 30 June 2023.
- Updates provided on clinical and preclinical development programs.
- Financial performance includes details of revenue, expenses, and net loss.
- Report highlights advancements in product pipeline and clinical trial progress.
- Ongoing collaborations and partnerships are noted.
- Corporate governance, risk factors, and future strategies are discussed.
- Significant investment in research and development is reflected in financials.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Abacus Storage King (ASK) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$1,741 |
Notice of withdrawal of NON-BINDING INDICATIVE PROPOSAL
|
26 Aug 2025 9:20AM |
$1.545 |
$1.325 |
fallen by
14.24%
|
|
| Kaili Resources Limited (KLR) 125C ORDINARY FULLY PAID |
Energy |
$12 |
Response to ASX Query Letter
|
26 Aug 2025 9:20AM |
$0.820 |
$0.083 |
fallen by
89.88%
|
|
KLR - Price-sensitive ASX Announcement
Full Release
Key Points
- Kaili Resources Limited responded to an ASX query regarding recent trading activity in its shares.
- The company asserts it is not aware of any undisclosed information that could explain the price change or increased trading volume.
- KLR confirms its compliance with ASX Listing Rule 3.1, emphasizing timely disclosure of material information.
- The response includes answers to specific ASX questions about financial and operational matters.
- KLR reaffirms it has made all relevant disclosures and there are no new material updates.
- The document serves as evidence of KLR’s commitment to ASX continuous disclosure requirements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kaili Resources Limited (KLR) 125C ORDINARY FULLY PAID |
Energy |
$12 |
Response to ASX Price Query
|
26 Aug 2025 9:20AM |
$0.820 |
$0.083 |
fallen by
89.88%
|
|
KLR - Price-sensitive ASX Announcement
Full Release
Key Points
- Kaili Resources Limited received a Price Query from ASX regarding recent share price and volume increases.
- The company is not aware of any information that has not been announced which could explain the unusual trading activity.
- Ongoing review of potential new business opportunities is part of normal operations, but no material developments have occurred.
- Kaili Resources confirmed compliance with ASX Listing Rule 3.1 regarding disclosure of material information.
- No directors or management are aware of any undisclosed matters or impending announcements.
- Movements in share price are attributed to market speculation rather than non-public material information.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mader Group Limited (MAD) ORDINARY FULLY PAID |
Industrials |
$1,408 |
FY25 Full Year Results, Final Dividend and FY26 Guidance
|
26 Aug 2025 9:20AM |
$8.350 |
$6.920 |
fallen by
17.13%
|
|
MAD - Price-sensitive ASX Announcement
Full Release
Key Points
- Mader Group reported a record annual revenue of $872.2 million for FY25, a 13% increase from the previous year.
- EBITDA for FY25 was $109.5 million, marking a 10% increase from the prior year.
- Net Profit After Tax (NPAT) for FY25 was $57.1 million, also a 13% increase year-on-year.
- The Australian segment saw a 17% revenue increase, contributing significantly to Mader Group's growth.
- The North America segment showed signs of recovery with an 8% revenue increase in the second half of FY25 compared to the first half.
- The Rest of World segment rebounded to pre-pandemic levels, showing an 81% revenue increase.
- Net debt reduced by 73% to $8.3 million by the end of FY25.
- A final fully franked dividend of 4.8 cents per share was declared for FY25, making the total dividends for the year 8.8 cents per share.
- For FY26, Mader Group projects revenue to be at least $1 billion with a forecasted NPAT of $65 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Carindale Property Trust (CDP) ORDINARY UNITS FULLY PAID |
Real Estate |
$453 |
Full Year Results Announcement
|
26 Aug 2025 9:20AM |
$5.380 |
$5.480 |
risen by
1.86%
|
|
Call 1300 880 160
Start a chat
Schedule a call
